We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CvergenX, Inc. Partners with National Cancer Institute to Predict Radiation Therapy Success

News   Apr 10, 2013

 
CvergenX, Inc. Partners with National Cancer Institute to Predict Radiation Therapy Success
 
 
 

RELATED ARTICLES

Simple Bile Acid Blood Test Could Tell Risk of Stillbirth

News

The discovery will help doctors identify the small number of women at most risk who require intervention to prevent stillbirth. This will allow the majority of women with intrahepatic cholestasis of pregnancy who are at a low risk to carry on their pregnancy normally.

READ MORE

Sensor Could Transform Clinical Care of People with Reproductive Disorders

News

The RAPTER platform was able to detect changes in LH pulse patterns in patients with reproductive disorders, and distinguish between different patient cohorts. Unlike current methods, the test is low-cost and can provide results instantly.

READ MORE

A Way to Improve Cancer Immunotherapy?

News

A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is used against a wide range of other cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE